Comparative Analysis of Commercial CCL21 and CCL21/IL1β Recombinant Proteins by in silico Tools

Document Type : Research Articles

Authors

• Ahdiyeh Shahtaghi ¹
• Ali Alam Shahnabadi ¹
• Kamelia Kohannezhad ¹
• Neda Amini ¹
• Maria Beihaghi ^{1, 2}

¹ Department of Biology, Kavian Institute of Higher Education, Mashhad, Iran

² Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran

https://doi.org/10.22067/jcmr.2021.69999.1005

Abstract

One of the newest diagnostic methods and treatment of cancer is to design new drugs. It is now possible to design a drug with desired properties in theory and evaluate its therapeutic effects through bioinformatics tools. Among the studied drugs, those based on cytokine genes, which increase the body's immunity against cancer, are of great interest. Cytokines are small proteins that play an essential role in cell signaling and can affect the function and behavior of surrounding cells. CCL21 chemokine is one of the cytokines that possess antitumor properties has the potential for chemoattraction of T lymphocytes and dendritic cells.  Interleukin 1 beta (IL1β) is a cytokine involving different cellular activities such as the activation of neutrophils, B-Cells, and T-Cells. In the present study, we designed a drug-based cytokine gene to activate T cells and B cells by inserting defined CCL21 epitope and IL1β peptide sequences into a protein construct. Molecular dynamics simulation was performed in Linux space using Gromex software. Results of RMSD, RMSF, and the radius of gyration obtained from the simulation showed the stability of both proteins, which indicated that there are no significant conformational differences between the commercial CCL21 and recombinant form. The interaction of synthetic construct and human CCL21 with the CCR7 receptor was also investigated by HADDOCK software. Obtained results showed no differences between these proteins, and recombinant protein has the same structural and conformational characteristics as human commercial CCL21.

Keywords

• Cytokine
• Chemokine
• CCL21
• Docking
• Molecular Dynamics Simulation

20.1001.1.20089147.2021.13.1.4.7

References

 

Akhter, N., Wu, B., Memon, A. M., and Mohsin, M. (2015). Probiotics and prebiotics associated with aquaculture: a review. Fish & shellfish immunology, 45(2), 733-741.

Beemiller, P., Jacobelli, J., and Krummel, M. F. (2012). Integration of the movement of signaling microclusters with cellular motility in immunological synapses. Nature immunology, 13(8), 787-795.

Boraschi, D., Tagliabue, A., and Miller, A. D. (2009). The immunostimulatory effect of IL‐1β in vivo is blocked by antisense peptides complementary to the loop sequence 163–171. FEBS letters, 583(4), 792-796.

Cyster, J. G. (1999). Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. Journal of Experimental Medicine, 189(3), 447-450.

Gaieb, Z., & Morikis, D. (2017). Detection of Side Chain Rearrangements Mediating the Motions of Transmembrane Helices in Molecular Dynamics Simulations of G Protein-Coupled Receptors. Computational and structural biotechnology journal, 15, 131-137.

Gollmer, K., Asperti-Boursin, F., Tanaka, Y., Okkenhaug, K., Vanhaesebroeck, B., Peterson, J. R., et al. (2009). CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood, 114(3), 580-588.

Jorgensen, A. S., Rosenkilde, M. M., Hjortø, G. M., Larsen, O., Legler, D. F., Uetz-von Allmen, E., et al. (2019). Biased signaling of CCL21 and CCL19 does not rely on N-terminal differences, but markedly on the chemokine core domains and extracellular loop 2 of CCR7. Frontiers in immunology, 10, 2156.

Joutoku, Z., Onodera, T., Matsuoka, M., Homan, K., Momma, D., Baba, R., Hishimura, R. (2019). CCL21/CCR7 axis regulating juvenile cartilage repair can enhance cartilage healing in adults. Scientific reports, 9(1), 5165.

Madej, T., Lanczycki, C. J., Zhang, D., Thiessen, P. A., Geer, R. C., Marchler-Bauer, A., and Bryant, S. H. (2013). MMDB and VAST+: tracking structural similarities between macromolecular complexes. Nucleic acids research, 42(D1), D297-D303.

McHugh, J. (2019). CCL21–CCR7 axis in RA: linking inflammation and bone erosion. Nature Reviews Rheumatology, 15(10), 576-576.

Moore, M. A. (2001). The role of chemoattraction in cancer metastases. Bioessays, 23(8), 674-676.

O'Donnell, T. J., Rubinsteyn, A., and Laserson, U. (2020). MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing. Cell Systems, 11(1), 42-48. e47.

Van Damme, J., De Ley, M., Opdenakker, G., Billiau, A., De Somer, P., and Van Beeumen, J. (1985). Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature, 314(6008), 266-268.

Zhao, D.-x., Li, Z.-j., Zhang, Y., Zhang, X.-n., Zhao, K.-c., Li, Y.-g., et al. (2014). Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas. Cellular immunology, 289(1), 155-161.